Ganga Pharmaceuticals Ltd - Prospectus Synopsis

Ganga Pharmaceuticals Ltd RHP

Registered Office : Gangatat Dhanvantri Marg , Gopcharpada Virar (E) , Palghar - 401305 , Maharashtra , India.

Phone : 91-250-6098333/444 Fax :

Email :ayurvedganga@gmail.com Website : www.ayurvedganga.com

Public offer of 10,24,000 equity shares of face value of Rs. 10/- each (Equity shares) of Ganga Pharmaceuticals Limited (The issure) for cash at a price Rs. 15/- per equity share (Including a share premium of Rs. 5/- per equity share) (Issue price) aggregating to Rs. 1.54 crores. The issue Constitutes 25.21% of the post issue paid up equity share capital of the company. This Being a fixed price, as per sub clause (4) of regulation 43 of The Sebi (ICDR) Regulations, 2009 as amended (The SEBI Regulations), The Issue of 10,24,000 equity shares, not less than 50% shall be avalable to retail individual investors and the remanining to individual applicants other than retail investors and other investor including corporate bodies or institutions irrespective of the number of shares applied for. If the retail individual investor category is entitled to more than 50% on proporationate basis, They shall be allotted that higher percentage. The face value of the equity shares is Rs. 10 each. The Issue price of equity shares Rs. 15/- each and The issue Price is 1.5 times of the face value.

Issue		Money Payable On
Opens On	Closes On	Application	Allotment
1/29/2016 12:00:00 AM	2/11/2016 12:00:00 AM	Rs 15 - 0	Rs 0 - 0
Minimum Application for shares in Nos : 8000 Further Multiples of : 8000

	Rs Cr	Lead Managers to the Issue
Project Cost	1.54	First Overseas Capital Ltd
Project Financed through Current Offer	1.54
Post Issue Equity Share Capital	1.54
Issue Price	Rs. 15

Projects
Deployment of production capacity

Promoted By

Listing At

Registrar to the Issue

Bharat B Sharma

Srijana B Sharma

KFin Techologies Ltd

ATTENTION INVESTORS

Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

Risk Disclosure on Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.

ATTENTION INVESTORS

Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Risk Disclosure on Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.

Ganga Pharmaceuticals Ltd - Prospectus Synopsis

ATTENTION INVESTORS

Risk Disclosure on Derivatives

We are ISO 27001:2013 Certified.

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

ATTENTION INVESTORS

Risk Disclosure on Derivatives

We are ISO 27001:2013 Certified.